Literature DB >> 7863938

Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients.

A Ruiz1, W I Ganz, M J Post, A Camp, H Landy, W Mallin, G N Sfakianakis.   

Abstract

PURPOSE: To determine whether thallium-201 brain single-photon emission CT could be used to make the distinction between central nervous system lymphoma and toxoplasma encephalitis, which may not be possible by routine MR and CT.
METHODS: A total of 37 patients with acquired immunodeficiency syndrome who had intracranial mass lesions found during a 9-month prospective study by either MR or CT underwent further evaluation with Tl-201 brain single-photon emission CT.
RESULTS: Twelve patients had increased intense focal Tl-201 uptake. All of these patients had either biopsy- or autopsy-proven lymphoma. Twenty-five of the patients studied had no Tl-201 brain uptake in the lesion(s); 24 of these patients had toxoplasma encephalitis on clinical follow-up. One patient with no Tl-201 uptake was found by cerebrospinal fluid analysis to have mycobacterium tuberculosis abscess.
CONCLUSION: Patients with acquired immunodeficiency syndrome who have intracranial mass lesions on MR or CT may benefit from Tl-201 brain single-photon emission CT because it can help distinguish between lymphoma and infectious lesions such as toxoplasma encephalitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7863938      PMCID: PMC8334279     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  16 in total

Review 1.  Brain imaging.

Authors:  R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Brain Abscess, Subdural Empyema, and Intracranial Epidural Abscess.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

3.  Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging.

Authors:  M Ricci; P Pantano; A Pierallini; D Di Stefano; A Santoro; L Bozzao; G L Lenzi
Journal:  Eur J Nucl Med       Date:  1996-05

4.  Lesion size determines accuracy of thallium-201 brain single-photon emission tomography in differentiating between intracranial malignancy and infection in AIDS patients.

Authors:  Robert J Young; Munir V Ghesani; Nolan J Kagetsu; Andrew J Derogatis
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

5.  Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma.

Authors:  Paul C Schroeder; M Judith Donovan Post; Elizabeth Oschatz; Alfred Stadler; Jocelyn Bruce-Gregorios; Majda M Thurnher
Journal:  Neuroradiology       Date:  2006-09-01       Impact factor: 2.804

6.  Case 11: a young woman with ring-enhancing brain lesions.

Authors:  Irene Cortese; Avindra Nath
Journal:  MedGenMed       Date:  2006-01-05

7.  Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS.

Authors:  R F Miller; M A Hall-Craggs; D C Costa; N S Brink; F Scaravilli; S B Lucas; I D Wilkinson; P J Ell; B E Kendall; M J Harrison
Journal:  Sex Transm Infect       Date:  1998-08       Impact factor: 3.519

Review 8.  Central nervous system lymphoma: characteristic findings on traditional and advanced imaging.

Authors:  I S Haldorsen; A Espeland; E-M Larsson
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-08       Impact factor: 3.825

Review 9.  Neurologic presentations of AIDS.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah Commins; Andrew Levine
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

Review 10.  A systematic approach to the diagnosis of suspected central nervous system lymphoma.

Authors:  Brian J Scott; Vanja C Douglas; Tarik Tihan; James L Rubenstein; S Andrew Josephson
Journal:  JAMA Neurol       Date:  2013-03-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.